AI-Enhanced ECGs for the Diagnosis of HFpEF: A Promising Frontier, But Not Yet a Standalone Solution
International Journal of Cardiovascular Sciences · 02.07.2026 · 39
DOI: 10.36660/ijcs.20250272 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cardiovascular Sciences, erschienen am 02.07.2026. Verfasst von Humberto Villacorta. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Heart Failure with preserved Ejection Fraction (HFpEF) is among the most challenging syndromes in contemporary cardiology. Despite accounting for nearly half of all heart failure cases, HFpEF remains chronically underdiagnosed and is associated with significant morbidity and mortality., The diagnosis of HFpEF is challenging and relies on clinical history, natriuretic peptide measurements, and echocardiography. Diagnostic scores have been developed that integrate these three key elements., Echocardiography is indispensable for identifying structural and functional criteria, but its availability and cost make [...]
Zitieren
APA
Villacorta, H. (2026). AI-Enhanced ECGs for the Diagnosis of HFpEF: A Promising Frontier, But Not Yet a Standalone Solution. International Journal of Cardiovascular Sciences, 39. https://doi.org/10.36660/ijcs.20250272
Vancouver
Villacorta H. AI-Enhanced ECGs for the Diagnosis of HFpEF: A Promising Frontier, But Not Yet a Standalone Solution. International Journal of Cardiovascular Sciences. 2026;39. doi:10.36660/ijcs.20250272
BibTeX
@article{Villacorta2026,
author = {Villacorta, Humberto},
title = {AI-Enhanced ECGs for the Diagnosis of HFpEF: A Promising Frontier, But Not Yet a Standalone Solution},
journal = {International Journal of Cardiovascular Sciences},
year = {2026},
volume = {39},
doi = {10.36660/ijcs.20250272}
}
EUVIMED